Horizon Therapeutics plc Announces EB Research Partnership Receives 2022 Horizon Prize, Powered by MIT Solve

--Organization Will Utilize GPS and Web Services to Build a Patient-Driven Platform for the Epidermolysis Bullosa (EB) Community and Accelerate a Cure -- Horizon Therapeutics plc (Nasdaq: HZNP), in

Related Keywords

Ireland ,Alex Amouyel ,Tim Walbert ,Catherine Riedel ,Ray Gordon ,Michael Hund ,Instagram ,Linkedin ,Twitter ,Eb Research Partnership ,Massachusetts Institute Of Technology ,Platform For The Epidermolysis Bullosa Eb Community ,Nasdaq ,Facebook ,Web Services To Builda Patient ,Organization Will Utilize ,Web Services ,Patient Driven Platform ,Epidermolysis Bullosa ,Horizon Prize ,Patient Driven Data Platform ,Rare Disease ,Research Partnership ,Horizon Therapeutics ,Executive Director ,Vula Mobile ,Massachusetts Institute ,Corporate Visibility ,Media Strategy ,Horizon ,Herapeutics ,Nnounces ,Research ,Partnership ,Eceives ,022 ,Prize ,Owered ,Solve ,